After the approval by regulatory authorities, Neste has closed the acquisition of Mahoney Environmental (Mahoney), a leading collector and recycler of used cooking oil in the United States, and its affiliated entities.
International investor groups, including the Asia Investor Group on Climate Change (AIGCC), have encouraged global governments to ensure they are planning for a sustainable recovery from the COVID-19 pandemic by factoring in climate change risk into economic recovery plans.
“Today we can produce PLA directly from glucose, but in the future, we will obtain it starting from organic wastes and, looking more forward, from carbon dioxide”. To say it – in this interview with Il Bioeconomista – is Danilo Porro, professor at University of Milano Bicocca and President of Galatea Biotech, one of the most innovative Italian industrial biotech start-up company. Headquartered in Milan, Galatea has developed a new process to produce PLA from glucose.
Interview by Mario Bonaccorso
This year’s third World Bioeconomy Forum (WCBEF) will be broadcast live from Ruka on September 10th, 2020. Due the current global pandemic the Advisory Board has decided to take a cautious approach and will provide delegates with a high-quality, interactive virtual event which will be moderated from Ruka in Finland. The event will deliver the usual high-level content, while at the same time as providing a unique experience for all bioeconomy stakeholders from around the world.
The full programme will be six hours in duration and will consist of four dedicated sessions: Regulators and Climate Change, Global Leaders and Financial World, Bioproducts around us, and Looking to the Future. The audience can contribute interactively on message walls and arrange online meetings with the other participants using the technology and channels provided. Continue reading
Syngenta and Novozymes are entering the commercialization phase of the biofungicide Taegro. The two companies originally joined forces in 2012 to develop and market the product, and have now received the first wave of product approvals in Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Honduras, Italy, Netherlands, Romania, Slovenia, Spain, and United Kingdom. Several other approvals are expected across the EU and Latin America during the next 12 months, which will enable multiple product launches in 2020.
Braskem, producer of polyolefins and biopolymers, is meeting the polypropylene raw material needs of medical manufacturing customers for the production of respiratory masks as well as protective medical gear.
“Within the bioeconomy we have a massive range of new tools and opportunities to exploit this chaotic time.” To say it – in this long exclusive interview with Il Bioeconomista – is Tony Duncan, CEO of Circa Group, the Australia-based biochemical company, which is revolutionizing the traditional chemical sector. With him we talk about his company and the bioeconomy in the COVID-19 age.
Interview by Mario Bonaccorso
An alliance has been launched in the European Parliament on the back of calls from 12 EU environment ministers who have signed an appeal for a green recovery from the COVID-19 pandemic. The “green recovery alliance” was launched last Monday at the initiative of Pascal Canfin, a French centrist MEP who chairs the European Parliament’s committee on environment and public health.
Nouryon introduced a natural film-forming polymer for use in high sun protection factor (SPF) emulsion sunscreens. SolAmaze™ Natural, which is bio-based and readily biodegradable, addresses the fast-growing consumer demand for natural and clean label ingredients in personal care products.
Clariant, a focused and innovative specialty chemical company, today announced it has started monthly production of 2 million liters of disinfectant at its facilities in Gendorf, Germany. This disinfectant is then directly or via repacking partners provided to regional hospitals and other vital institutions in Bavaria, who are currently facing limited availability of this critical product during the COVID-19 outbreak.
IL BIOECONOMISTA 